Granahan Investment Management, LLC Neoleukin Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $582,789 - $971,315	-125,331 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $421,957 - $673,736	-69,745 Reduced 35.75%	125,331 $906,000
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $50,229 - $71,399	-5,442 Reduced 2.71%	195,076 $1.8 Million
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $515,494 - $722,424	-45,781 Reduced 18.59%	200,518 $2.47 Million
Q4 2020 Feb 12, 2021	SELL	$10.17 - $14.56 $510,656 - $731,086	-50,212 Reduced 16.93%	246,299 $3.47 Million
Q3 2020 Nov 12, 2020	BUY	$9.68 - $17.01 $210,085 - $369,168	21,703 Added 7.9%	296,511 $3.56 Million
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $2.73 Million - $4.69 Million	274,808 New	274,808 $4.56 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.